Year |
Citation |
Score |
2022 |
Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6 |
0.327 |
|
2022 |
Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6 |
0.327 |
|
2022 |
Shafi S, Aung TN, Xirou V, Gavrielatou N, Vathiotis IA, Fernandez A, Moutafi M, Yaghoobi V, Herbst RS, Liu LN, Langermann S, Rimm DL. Quantitative assessment of Siglec-15 expression in lung, breast, head, and neck squamous cell carcinoma and bladder cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology. 102: 1143-1149. PMID 35581307 DOI: 10.1038/s41374-022-00796-6 |
0.327 |
|
2020 |
Ahmed FS, Gaule P, McGuire J, Patel KK, Blenman KR, Pusztai L, Rimm DL. PD-L1 protein expression on both tumor cells and macrophages are associated with response to neoadjuvant durvalumab in triple negative breast cancer (TNBC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32709714 DOI: 10.1158/1078-0432.CCR-20-1303 |
0.306 |
|
2020 |
Ding A, Villarroel-Espindola F, Ducler A, Henick BS, Desai S, Gianino N, Zugazagoitia J, Rimm DL, Robert A, Cruzalegui F, Ferré P, Herbst R, Sanmamed M, Chen L, Schalper KA. Abstract 5525: VISTA/PSGL1 axis as a dominant immunomodulatory pathway in human non-small cell lung cancer Immunology. 80: 5525-5525. DOI: 10.1158/1538-7445.Am2020-5525 |
0.306 |
|
2017 |
Pelekanou V, Carvajal-Hausdorf DE, Altan M, Wasserman B, Carvajal-Hausdorf C, Wimberly H, Brown J, Lannin D, Pusztai L, Rimm DL. Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance. Breast Cancer Research : Bcr. 19: 91. PMID 28784153 DOI: 10.1186/s13058-017-0884-8 |
0.31 |
|
2014 |
Wimberly H, Han G, Pinnaduwage D, Murphy LC, Yang XR, Andrulis IL, Sherman M, Figueroa J, Rimm DL. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Research and Treatment. 146: 657-67. PMID 25007965 DOI: 10.1007/s10549-014-3050-3 |
0.314 |
|
2014 |
Jeon YJ, Khelifa S, Feng Y, Lau E, Cardiff R, Kim H, Rimm DL, Kluger Y, Ronai Z. Abstract 2440: RNF5 mediates ER stress-induced degradation of SLC1A5 in breast cancer Cancer Research. 74: 2440-2440. DOI: 10.1158/1538-7445.Am2014-2440 |
0.302 |
|
2011 |
Michal AM, Peck AR, Tran TH, Liu C, Rimm DL, Rui H, Benovic JL. Differential expression of arrestins is a predictor of breast cancer progression and survival. Breast Cancer Research and Treatment. 130: 791-807. PMID 21318602 DOI: 10.1007/S10549-011-1374-9 |
0.31 |
|
2011 |
Peck A, Witkiewicz A, Liu C, Klimowicz A, Stringer G, Pequignot E, Freydin B, Yang N, Tran T, Rosenberg A, Hooke J, Kovatich A, Shriver C, Rimm D, Magliocco A, et al. P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-06-24 |
0.305 |
|
2010 |
Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL. In Situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis American Journal of Pathology. 176: 2131-2138. PMID 20228222 DOI: 10.2353/ajpath.2010.090712 |
0.304 |
|
2010 |
Nadler Y, González AM, Camp RL, Rimm DL, Kluger HM, Kluger Y. Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 466-73. PMID 19717535 DOI: 10.1093/Annonc/Mdp346 |
0.315 |
|
2007 |
Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Research. 67: 2932-7. PMID 17409397 DOI: 10.1158/0008-5472.Can-06-4511 |
0.313 |
|
2007 |
Zerkowski MP, Camp RL, Burtness BA, Rimm DL, Chung GG. Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome. Cancer Investigation. 25: 19-26. PMID 17364553 DOI: 10.1080/07357900601128825 |
0.317 |
|
2005 |
Kluger HM, Chelouche Lev D, Kluger Y, McCarthy MM, Kiriakova G, Camp RL, Rimm DL, Price JE. Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Research. 65: 5578-87. PMID 15994930 DOI: 10.1158/0008-5472.Can-05-0108 |
0.308 |
|
Show low-probability matches. |